Replimune Group Inc (NASDAQ:REPL)

20.79
Delayed Data
As of Jan 21
 +0.19 / +0.92%
Today’s Change
19.71
Today|||52-Week Range
46.64
-23.28%
Year-to-Date
No recent news for Replimune Group Inc.

Today’s Trading

Previous close20.60
Today’s open20.15
Day’s range20.12 - 21.56
Volume13,145
Average volume (3 months)234,785
Market cap$1.1B
Data as of 4:00pm ET, 01/21/2022

Growth & Valuation

Earnings growth (last year)-13.84%
Earnings growth (this year)-23.20%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.10-0.79%
RCKTRocket Pharmaceutica...-0.62-3.79%
AXSMAxsome Therapeutics ...-3.03-11.34%
RGNXRegenxbio Inc-0.45-1.77%
Data as of 4:37pm ET, 01/21/2022

Financials

Next reporting dateFebruary 3, 2022
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$0.00
Annual profit (last year)-$80.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Woburn, Massachusetts

Forecasts